Stock Scorecard
Stock Summary for Arcutis Biotherapeutics Inc (ARQT) - $15.02 as of 7/25/2025 1:35:01 PM EST
Total Score
7 out of 30
Safety Score
34 out of 100
Currently on the following lists
None
Tim's Recommendation
Avoid
Growth List Algorithm Criteria for ARQT
| Positive Quarterly and Annual earnings growth | |
| P/E ratio less than Industry P/E Ratio | |
| P/E ratio less than Sector P/E Ratio | |
| P/E ratio that is half the Annual earnings growth rate (or less) | |
| Positive net cash position the past year and most recent quarter | |
| Equity to debt ratio greater than 0.75 for past year and most recent quarter | |
| Positive net income past year and 12 trailing months | |
| Free cash flow ratio greater than 0 and less than 10 |
Small Cap List Algorithm Criteria for ARQT
| Revenue growing by at least 20% average per year over the last 5 years | |
| Market Capitalization under 2 billion | |
| Price to Sales (P/S) ratio 12 trailing months less than Industry P/S ratio twelve trailing months | |
| Price to Sales (P/S) ratio 12 trailing months less than Sector P/S ratio twelve trailing months | |
| Net Income past year > Net Income prior year OR Net Income 12 trailing months > Net Income prior year OR Net Income 12 trailing months > Net Income past year |
Dividend List Algorithm Criteria for ARQT
| Declared an ex-dividend date | |
| Forward annual dividend rate greater than 2 | |
| Positive net cash position the past year and most recent quarter | |
| Equity to debt ratio greater than 0.75 for past year and most recent quarter | |
| Current ratio most recent quarter greater than 2 | |
| Cash Flow per Share greater than Trailing Dividend Rate |
Bonus Criteria for ARQT
| P/E ratio less than five-year Average P/E ratio | |
| Last Price to 52 Week Low Ratio Less Than 1 | |
| Total Cash Per Share > Last Day Price | |
| P/S Ratio < 1 | |
| P/B Ratio < 1 |
Safety Rating Criteria for ARQT (34 out of 100)
| Stock Price Rating (Max of 10) | 6 |
| Historical Stock Price Rating (Max of 10) | 7 |
| Stock Price Trend (Max of 10) | 2 |
| Book Value (Max of 10) | 2 |
| Book Value to Price (Max of 10) | 0 |
| Analyst Buy Ratings (Max of 5) | 4 |
| Analyst Strong Buy Ratings (Max of 5) | 4 |
| Dividend Yield Percentage (Max of 10) | 0 |
| Operating Margin (Max of 10) | 0 |
| Trading Volume (Max of 10) | 9 |
| Price to Earnings (Max of 10) | 0 |
| Geopolitical Risk Adjustment (Always 0 for USA or a Negative Number for Non-USA) | 0 |
Latest News for for ARQT
Financial Details for ARQT
Company Overview |
|
|---|---|
| Ticker | ARQT |
| Company Name | Arcutis Biotherapeutics Inc |
| Country | USA |
| Description | Arcutis Biotherapeutics, Inc., a biopharmaceutical company, focuses on developing and commercializing treatments for dermatological diseases. The company is headquartered in Westlake Village, California. |
| Sector Name | LIFE SCIENCES |
| Industry Name | PHARMACEUTICAL PREPARATIONS |
| Most Recent Quarter | 3/31/2025 |
| Next Earnings Date | 8/13/2025 |
Stock Price History |
|
| Last Day Price | 15.02 |
| Price 4 Years Ago | 20.74 |
| Last Day Price Updated | 7/25/2025 1:35:01 PM EST |
| Last Day Volume | 1,206,342 |
| Average Daily Volume | 1,816,844 |
| 52-Week High | 17.75 |
| 52-Week Low | 7.86 |
| Last Price to 52 Week Low | 91.09% |
Valuation Measures |
|
| Trailing PE | N/A |
| Industry PE | 21.96 |
| Sector PE | 41.43 |
| 5-Year Average PE | -18.11 |
| Free Cash Flow Ratio | 33.38 |
| Industry Free Cash Flow Ratio | 17.72 |
| Sector Free Cash Flow Ratio | 32.93 |
| Current Ratio Most Recent Quarter | 3.55 |
| Total Cash Per Share | 0.45 |
| Book Value Per Share Most Recent Quarter | 1.20 |
| Price to Book Ratio | 12.46 |
| Industry Price to Book Ratio | 33.70 |
| Sector Price to Book Ratio | 30.75 |
| Price to Sales Ratio Twelve Trailing Months | 8.35 |
| Industry Price to Sales Ratio Twelve Trailing Months | 136.89 |
| Sector Price to Sales Ratio Twelve Trailing Months | 40.01 |
| Analyst Buy Ratings | 4 |
| Analyst Strong Buy Ratings | 3 |
Share Statistics |
|
| Total Shares Outstanding | 119,202,000 |
| Market Capitalization | 1,790,414,040 |
| Institutional Ownership | 108.79% |
Dividends |
|
| Ex-Dividend Date | N/A |
| Previous Dividend Amount | 0.0000 |
| Current Dividend Amount | 0.0000 |
| Total Years Dividend Increasing | N/A |
| Trailing Annual Dividend Rate | 0.00 |
| Trailing Annual Dividend Yield | 0.00% |
| Forward Annual Dividend Rate | 0.00 |
| Forward Annual Dividend Yield | 0.00% |
| 5-Year Dividend Payments Count | 0 |
| 3-Year Average Dividend Yield | 0.00% |
| 5-Year Average Dividend Yield | 0.00% |
| 1-Year Dividend Growth Rate Percentage | 0.00% |
| 3-Year Dividend Growth Rate Percentage | 0.00% |
| 5-Year Dividend Growth Rate Percentage | 0.00% |
| All-Time Dividend Growth Rate Percentage | 0.00% |
| Dividend Payout Ratio | N/A |
Income Statement |
|
| Quarterly Earnings Growth YOY | 0.00% |
| Annual Earnings Growth | 46.58% |
| Reported EPS 12 Trailing Months | -1.04 |
| Reported EPS Past Year | -0.20 |
| Reported EPS Prior Year | -1.16 |
| Net Income Twelve Trailing Months | -129,717,000 |
| Net Income Past Year | -140,039,000 |
| Net Income Prior Year | -262,140,000 |
| Quarterly Revenue Growth YOY | 32.80% |
| 5-Year Revenue Growth | 0.00% |
| Operating Margin Twelve Trailing Months | -37.20% |
Balance Sheet |
|
| Total Cash Most Recent Quarter | 53,104,000 |
| Total Cash Past Year | 71,335,000 |
| Total Cash Prior Year | 88,398,000 |
| Net Cash Position Most Recent Quarter | -54,514,000 |
| Net Cash Position Past Year | -35,868,000 |
| Long Term Debt Past Year | 107,203,000 |
| Long Term Debt Prior Year | 201,799,000 |
| Total Debt Most Recent Quarter | 107,618,000 |
| Equity to Debt Ratio Past Year | 0.60 |
| Equity to Debt Ratio Most Recent Quarter | 0.57 |
| Total Stockholder Equity Past Year | 157,541,000 |
| Total Stockholder Equity Prior Year | 88,667,000 |
| Total Stockholder Equity Most Recent Quarter | 142,658,000 |
Free Cash Flow |
|
| Free Cash Flow Twelve Trailing Months | -116,686,000 |
| Free Cash Flow Per Share Twelve Trailing Months | -0.98 |
| Free Cash Flow Past Year | -112,301,000 |
| Free Cash Flow Prior Year | -247,485,000 |
Options |
|
| Put/Call Ratio | 0.02 |
| Has Options | Options Chain |
| Liquidity Rating | |
Technical Analysis |
|
| Yahoo Finance Chart | Yahoo Finance Chart |
| MACD | 0.27 |
| MACD Signal | 0.28 |
| 20-Day Bollinger Lower Band | 12.29 |
| 20-Day Bollinger Middle Band | 14.30 |
| 20-Day Bollinger Upper Band | 16.32 |
| Beta | 1.77 |
| RSI | 52.97 |
| 50-Day SMA | 12.57 |
| 150-Day SMA | 11.14 |
| 200-Day SMA | 13.37 |
System |
|
| Modified | 7/24/2025 5:46:01 PM EST |